(3S,6S,9S,12S)-6-((1H-Indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone

Catalog No. :
ACIYDE442
CAS No. :
164991-89-3
Molecular Formula :
C24H32N6O5
Molecular Weight :
484.56

IUPAC Name:(3S,6S,9S,12S)-6-((1H-indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone

(3S,6S,9S,12S)-6-((1H-Indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3S,6S,9S,12S)-6-((1H-Indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone
IUPAC Name(3S,6S,9S,12S)-6-((1H-indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone
MDL No.MFCD30725502
Molecular FormulaC24H32N6O5
Molecular Weight484.56
SMILESCC(C)[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](C)NC1=O
InChI KeyVBQDUSUKSGAFMN-OACKDKIBSA-N
Synonymsegetalin B;product/154129;Cyclo(L-alanylglycyl-L-valyl-L-alanyl-L-tryptophyl);Cyclo(AGAVW);(3S,6S,9S,12S)-6-((1H-Indol-3-yl)methyl)-12-isopropyl-3,9-dimethyl-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone;Segetalin B, 10 mM in DMSO
CAS No.164991-89-3
PubChem CID10345235

Synthetic Route by SureRoute

1. ACIYDE442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYDE442 route product structure diagram
    ACIYDE442164991-89-3
Inquiry

2. ACIYDE442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYDE442 route product structure diagram
    ACIYDE442164991-89-3
Inquiry

Comments (0)